Medicine & Life Sciences
Squamous Cell Carcinoma of Head and Neck
100%
Cetuximab
65%
Head and Neck Neoplasms
51%
Survival
37%
Squamous Cell Carcinoma
35%
Peripheral Blood Stem Cells
31%
Stem Cell Transplantation
31%
Transplants
30%
Neoplasms
29%
Bone Marrow Transplantation
26%
130-nm albumin-bound paclitaxel
26%
Granulocyte Colony-Stimulating Factor
25%
Drug Therapy
25%
Oropharyngeal Neoplasms
25%
Sarcoma
25%
Therapeutics
24%
Graft vs Host Disease
24%
Radiotherapy
23%
Peripheral Blood Stem Cell Transplantation
23%
Cisplatin
22%
Autologous Transplantation
22%
palbociclib
22%
Induction Chemotherapy
22%
Progression-Free Survival
21%
Whole-Body Irradiation
20%
Bone Marrow
19%
Recurrence
18%
Unrelated Donors
17%
Docetaxel
17%
Tissue Donors
17%
pembrolizumab
17%
Stem Cells
17%
Homologous Transplantation
16%
Radiation
16%
Neutrophils
16%
Transplant Recipients
16%
Granulocytes
15%
Neck
13%
Cyclophosphamide
13%
Neoplasm Metastasis
13%
Safety
12%
dusquetide
12%
Breast Neoplasms
12%
Bone Neoplasms
12%
Platinum
11%
Albumin-Bound Paclitaxel
11%
temsirolimus
10%
Allogeneic Cells
10%
Mouth
10%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10%